Evidence map›Paper›PMID 35725419›Full record

ArticleBMC pregnancy and childbirth2022

The association between chronic liver diseases and preeclampsia.

Sapir Nachshon, Eran Hadar, Ron Bardin, Shiri Barbash-Hazan, Adi Borovich, Marius Braun, Anat Shmueli

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sapir NachshonSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eran HadarSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ron BardinSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shiri Barbash-HazanSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Adi BorovichSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Marius BraunSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Anat ShmueliSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. anatshmu79@gmail.com.
Rabin Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreeclampsia is a multisystem disorder characterized by an abnormal vascular response to placentation associated with increased systemic vascular resistance. As liver involvement is one of the main clinical features of preeclampsia, we sought to determine if there is an association between chronic liver diseases and preeclampsia.

methodsA retrospective matched case-control analysis was conducted in a tertiary medical center. Three hundred eleven (311) pregnant women with preexisting chronic liver disease (study group), including viral and autoimmune hepatitis, non-alcoholic fatty liver, Wilson disease, and cirrhosis, were match for age, parity, and number of fetuses to 933 healthy pregnant women (control group). The primary outcome measure was the incidence of preeclampsia in each group. Secondary outcome measures were obstetrical and neonatal complications. Confounders found to be significant on univariate analysis were evaluated using logistic regression models, and odds ratios (OR) and confidence intervals (CI) were calculated.

resultsPreeclampsia was diagnosed in 28 women (9.0%) in the study group and 33 women (3.54%) in the control group (p < 0.001). On multivariate analysis adjusted for maternal age, parity, previous preeclampsia, chronic hypertension, gestational diabetes mellitus, pregestational diabetes mellitus, antiphospholipid syndrome, and mode of conception, chronic liver disease was found to be an independent risk factor for preeclampsia (aOR 2.631, 95% CI 1.518-4.561). Although there was no difference in the gestational week at delivery between the groups (38.6 ± 2.13 vs. 38.8 ± 2.17 for study and control group, respectively, p = 0.410), the study group had a lower mean neonatal birthweight (3088 ± 551 vs. 3182 ± 566 g, p = 0.011). There were no between-group differences in the other parameters evaluated.

conclusionIn our study, preexisting chronic liver disease was associated with a 2.6-fold increased risk of preeclampsia.

Indexed as

Diabetes, GestationalLiver DiseasesPre-EclampsiaFemaleHumansInfant, NewbornMaternal AgePregnancyRetrospective StudiesRisk FactorsChronic Liver DiseaseHypertensionPreeclampsia

Identifiers

PMID35725419
PMCPMC9208086
OpenAlexW4283166376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.